Trial Profile
Effects of Ranolazine in Patients With Angina Due to Right Ventricular Ischemia in Pulmonary Arterial Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 May 2015
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- 19 Nov 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jun 2012 Planned end date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 18 Aug 2010 New trial record